Abstract:Migraines in the modern day represent a significant problem, however, the current treatment options come with significant risks. This paper reviews rimegepant, its pharmacological characteristics, and possible synthetic pathways, focusing on ease of synthesis, green chemistry, and scalability. The review reveals a biocatalytic approach to be a promising candidate for industrial scale-up with relatively mild conditions.
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.